Sign in
CompletedNo phase

Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults

Key facts

Who runs it
University Hospital, Bordeaux
Where
France1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
51 people enrolled
Started
19 Sept 2025
Ended
5 Apr 2026
Type of study
Interventional
Treatments tested
  • Questionnaire
Record updated
25 June 2026

Who can take part

Age
18 years to 45 years
Sex
Women only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Women diagnosed with acute leukemia, who underwent allogeneic hematopoietic stem cell transplantation in adulthood (>18 years),
  • Aged 20 to 45 at the time of evaluation,
  • At least 2 years post-transplant
  • French-speaking patients, without comprehension disorders, and literate,
  • No objection to participation

Who cannot take part

  • Premature ovarian failure prior to management of haemopathy, post-transplant relapse,
  • Patient under legal protection

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Gynecological impact and infertility are major issues for women after allogeneic hematopoietic stem cell transplantation.

Read full original descriptionShow less

The aim of the present study is to investigate the prevalence of gynecological complications after allogeneic hematopoietic stem cell transplantation for acute leukemia in adulthood. By conducting a single-center retrospective descriptive analysis, the prevalence, follow-up and treatment of gynecological complications -including premature ovarian failure, vulvovaginal graft-versus-host-disease, cervical pathology- will be analysed

The group in the trial

  • QuestionnaireTreatment being tested

    A standardized questionnaire was specifically developed for the study to explore: * Women's socio-demographic data * Data about their hematological disease (type of leukemia, conditioning protocol, relapses, graft-versus-host disease etc.) * Information received by patients prior to transplantation concerning gynecological complications * Symptoms, screening, diagnosis and treatment of the main gynecological complications * Patients fertility (spontaneous or after assisted reproductive treatments)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Gynecological and Fertility Impact of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia Diagnosed in Adulthood (GYNEGRAFT)
Record updated
25 June 2026